CLEARPOINT NEURO, INC. COMMON STOCK CLPT 深 沪
已收盘 09-19 16:00:00 美东时间
12.14
+0.480
+4.12%
华盛通- 最 高12.14
- 今 开12.00
- 成交量 11.63万股
- 最 低 11.74
- 昨 收 11.66
- 总市值 3.27亿
- 52周最高 13.47
- 市盈率 静 --
- 换手率 0.43%
- 52周最低 4.05
- 委 比 0.00%
- 总股本 2697.63万
- 历史最高 31.29
- 量 比 0.50
- 振 幅 3.43%
- 历史最低 2.86
- 每 手 1
- 风险率 1.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ClearPoint Neuro Preempts Convertible Note Obligations
ClearPoint Neuro (CLPT) has provided an announcement. ClearPoint Neuro, Inc. ha...
08-27 04:29
ClearPoint Neuro fully repays $10M converted note
ClearPoint Neuro (NASDAQ:CLPT) announced that on August 23, 2024, it provided for the full early repayment of the principal amount and interest on a $10M convertible note held by PTC Therapeutics whic...
08-27 04:13
新浪财经ESG：CLPT 路孚特（Refinitiv）ESG评级调升至C-
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
06-17 07:01
ClearPoint Neuro Stockholders Approve Key Proposals and Directors
ClearPoint Neuro (CLPT) has shared an update. At ClearPoint Neuro, Inc.’s Annua...
05-16 18:23
ClearPoint Neuro Engages Stakeholders with Updated Presentation
ClearPoint Neuro (CLPT) has shared an announcement. Clearpoint Neuro has update...
05-08 04:28
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)
NEW YORK, April 8, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ClearPoint Neuro, Inc. (NASDAQ: CLPT) on behalf of the company's shareholders. The investi...
04-08 21:15
Clearpoint Neuro Inc.2023财年实现净利润-22.09百万美元，同比减少34.37%
12月31日，Clearpoint Neuro Inc.（CLPT.US）公布财报，公告显示公司2023财年净利润为-22.09百万美元，同比减少34.37%...
03-13 03:20
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
03-12 17:35
Earnings Outlook For ClearPoint Neuro
ClearPoint Neuro (NASDAQ:CLPT) is set to give its latest quarterly earnings rep...
03-12 02:01
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Enveric Biosciences (NASDAQ:ENVB) stock rose 162.3% to $2.18 during Th...
02-29 21:07
